EUVIMEDEUVIMED entdecken
Open Access

Treatment of Autism Spectrum Disorder in Children and Adolescents

Melissa DeFilippis, Karen Dineen Wagner

Psychopharmacology Bulletin · 12.08.2025 · 46 (2) · 18-41

DOI: 10.64719/pb.4346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychopharmacology Bulletin, online erschienen am 12.08.2025. Verfasst von Melissa DeFilippis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Drs. DeFilippis, MD, Wagner, MD, PhD, Department of Psychiatry and Behavioral Sciences University of Texas Medical Branch, USA. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorder is a diagnosis that includes significant social communication deficits/delays along with restricted patterns of interests and behaviors. The prevalence of this diagnosis has increased over the past few decades, and it is unclear whether this is solely attributable to the increased awareness of milder forms of the disorder among medical providers. The current treatment options for the core symptoms of autism are limited to psychosocial therapies, such as applied behavior analysis. Medications have been most effective in treating the associated behavioral symptoms of autism, though studies have examined potential benefits in some of the core symptoms of autism with certain medications, especially the repetitive behaviors often seen with this diagnosis. Risperidone and aripiprazole are currently the only medications FDA approved for symptoms associated with autism spectrum disorders, targeting the irritability often seen with this diagnosis. Children and adolescents with autism spectrum disorder appear to be more susceptible to adverse effects with medications; therefore, initiation with low doses and titrating very slowly is recommended. Some complementary alternative treatments have been researched as possible treatments in autism, though evidence supporting many of these is very limited.

Schlagwörter

Stichwörter der Autor:innen

autism spectrum disorderpsychopharmacologypsychotherapytreatment

Autor:innen und Institutionen

  • Drs. DeFilippis, MD, Wagner, MD, PhD, Department of Psychiatry and Behavioral Sciences University of Texas Medical Branch, USA.

Zitieren

APA

DeFilippis, M., & Wagner, K. D. (2025). Treatment of Autism Spectrum Disorder in Children and Adolescents. Psychopharmacology Bulletin, 46(2), 18-41. https://doi.org/10.64719/pb.4346

Vancouver

DeFilippis M, Wagner KD. Treatment of Autism Spectrum Disorder in Children and Adolescents. Psychopharmacology Bulletin. 2025;46(2):18-41. doi:10.64719/pb.4346

BibTeX
@article{DeFilippis2025,
  author = {DeFilippis, Melissa and Wagner, Karen Dineen},
  title = {Treatment of Autism Spectrum Disorder in Children and Adolescents},
  journal = {Psychopharmacology Bulletin},
  year = {2025},
  volume = {46},
  number = {2},
  pages = {18--41},
  doi = {10.64719/pb.4346}
}
Kostenlos starten →